- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed/Refractory Systemic Light Chain Amyloidosis in United States
Total 562 results
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult... and other conditionsUnited States, Italy
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed or Refractory Large B-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterAstraZeneca; Aravive Biologics IncActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
MedImmune LLCCompletedRelapsed/Refractory Aggressive B-cell LymphomasUnited States
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid TumorsUnited States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
Janssen Research & Development, LLCCity of Hope Medical CenterRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Mantle Cell LymphomaUnited States, France, Spain, United Kingdom, Netherlands, Germany
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory Mantle Cell LymphomaUnited States, Netherlands, Germany, France
-
Great Ormond Street Hospital for Children NHS Foundation...Medical Research Council; UCL Great Ormond Street Institute of Child HealthRecruitingRelapsed/Refractory T-cell Acute Lymphoid LeukaemiaUnited Kingdom
-
Ionis Pharmaceuticals, Inc.Active, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Molecular Templates, Inc.TerminatedRelapsed and/or Refractory Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
UNC Lineberger Comprehensive Cancer CenterGenzyme, a Sanofi CompanyRecruitingMultiple Myeloma | Aging | Relapse | Co-morbidity | RefractoryUnited States
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Cyclacel Pharmaceuticals, Inc.CompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma | Recurrent Atypical... and other conditionsUnited States, Australia, Canada
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitationDiabetic Foot | Amputation | Diabetic Ulcer of Left Foot | Diabetic Ulcer of Right FootUnited States
-
University of BirminghamCancer Research UK; GenmabRecruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited Kingdom
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
Ira WinerRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Malignant Ovarian Epithelial Tumor | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States
-
Roswell Park Cancer InstituteActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Nationwide Children's HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B Cell Leukemia | B-cell Non Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumAbbottTerminatedAcute Lymphoblastic Leukemia | Relapsed Pediatric ALL | Recurrent Pediatric ALL | Refractory Pediatric ALLUnited States
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
Incyte CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia